IL6 and COVID-19: In a study of COVID-19 patients by Mehta et al. [41], it was observed that a hyperactivated immune system with a hazardous elevation in inflammatory cytokines like IL-1b, IL-2R, IL-6, and TNF-α had been developed in SARS-CoV-2 patients with severe conditions.